In terms of prognosis, PRR11 expression was strongly correlated with the poor prognosis of RCC patients, and in contrast to PRR11, high expression of FBXW7 significantly improved the overall survival of RCC patients (Figure 3H-I). This evidence concerns the gene FBXW7 and renal cell carcinoma.